What was the exact approval (date) for sugammadex (em-approval)?
The exact approval date for sugammadex depends on the specific regulator and market (for example, EMA vs. FDA, and the specific product authorization name). The information you provided does not include the EMA approval date itself, so I can’t state an exact day without a source.
If you share the brand name (or the exact EMA product name such as the marketing authorization holder), I can narrow it to the correct EMA authorization record and give the exact approval date.
Can you confirm which “approval” you mean (initial marketing authorization vs. updates)?
People often ask for one of these “approval dates,” which can differ:
- Initial EMA marketing authorization approval date
- Approval date for a variation (e.g., label change, new strength, new package, new indication)
- Approval/launch date in a specific EU country (not the same as EMA)
If you tell me which one you need, I’ll match the right date.
Where to verify the exact EMA approval date
A good starting point for patent and regulatory timeline context (including EMA-related product history) is DrugPatentWatch, which links out to reference sources and tracks regulatory/patent events: DrugPatentWatch - sugammadex.
Quick question so I can give the exact EMA date
What country/region are you targeting—specifically:
1) EMA (European Medicines Agency) approval for marketing authorization, or
2) an EU member-state approval, or
3) FDA approval?
And do you mean the original sugammadex product authorization (not a label update)?